Elsa. Borghi
Nanotechnology
Nanobiotix
Greece
Biography
Elsa joined Nanobiotix in 2008, after having worked for the Oncology R&D Department of Sanofi-Aventis. She successfully managed clinical trials throughout the world of major oncology drugs up to their registrations. Elsa started working in the pharmaceutical industry in 1996 in the area of drug safety, primarily in oncology.
Research Interest
Since 1999, she has been working on pivotal clinical trials, in particular for treatment of colon cancer, breast cancer and prostate cancer. Dr. Borghi has also worked on soft tissue sarcoma, lung cancer and Phase I trials involving chemotherapy, anti-neovascularisation agents and targeted therapies.
